| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update | Annals of the Rheumatic Diseases | 2017 | 1.6K |
| Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE | Nature Immunology | 2007 | 1.1K |
| Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force | Annals of the Rheumatic Diseases | 2016 | 814 |
| Pathologically expanded peripheral T helper cell subset drives B cells in rheumatoid arthritis | Nature | 2017 | 455 |
| Fas gene mutations in the Canale-Smith syndrome, an inherited lymphoproliferative disorder associated with autoimmunity | New England Journal of Medicine | 1996 | 438 |
| Genome scan of human systemic lupus erythematosus: evidence for linkage on chromosome 1q in African-American pedigrees | Proceedings of the National Academy of Sciences of the United States of America | 1998 | 401 |
| Identification of a central role for complement in osteoarthritis | Nature Medicine | 2011 | 378 |
| Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry | Nature Immunology | 2019 | 369 |
| Type I interferon in the pathogenesis of lupus | Journal of Immunology | 2014 | 325 |
| Whole-genome sequencing identifies EN1 as a determinant of bone density and fracture | Nature | 2015 | 308 |
| Complement receptor 2/CD21- human naive B cells contain mostly autoreactive unresponsive clones | Blood | 2010 | 304 |
| CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway | Journal of Experimental Medicine | 1995 | 252 |
| Smoking intensity, duration, and cessation, and the risk of rheumatoid arthritis in women | American Journal of Medicine | 2006 | 245 |
| A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome | British Journal of Rheumatology | 2002 | 236 |
| In situ B cell-mediated immune responses and tubulointerstitial inflammation in human lupus nephritis | Journal of Immunology | 2011 | 216 |
| Elevated high-sensitivity C-reactive protein levels are associated with local inflammatory findings in patients with osteoarthritis | Osteoarthritis and Cartilage | 2007 | 212 |
| Identification of mothers at risk for congenital heart block and other neonatal lupus syndromes in their children. Comparison of enzyme-linked immunosorbent assay and immunoblot for measurement of anti-SS-A/Ro and anti-SS-B/La antibodies | Arthritis and Rheumatism | 1993 | 174 |
| Ligation of CD40 on fibroblasts induces CD54 (ICAM-1) and CD106 (VCAM-1) up-regulation and IL-6 production and proliferation | Journal of Leukocyte Biology | 1995 | 172 |
| Innate immune system activation in osteoarthritis: is osteoarthritis a chronic wound? | Current Opinion in Rheumatology | 2008 | 165 |
| Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine | Annals of the Rheumatic Diseases | 2010 | 164 |
| Adalimumab therapy for childhood uveitis | Journal of Pediatrics | 2006 | 162 |
| Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update | Annals of the Rheumatic Diseases | 2016 | 156 |
| Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period | Annals of the Rheumatic Diseases | 2015 | 155 |
| Association between FcgammaRIIa-R131 allotype and bacteremic pneumococcal pneumonia | Clinical Infectious Diseases | 2000 | 152 |
| Systemic lupus erythematosus arising during interferon-alpha therapy for cryoglobulinemic vasculitis associated with hepatitis C | Clinical Rheumatology | 2005 | 134 |
